Global RNA Sample Preservation Solution Market Growth 2026-2032
Description
The global RNA Sample Preservation Solution market size is predicted to grow from US$ 258 million in 2025 to US$ 371 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.
RNA Sample Preservation Solution is a specialized biological reagent formulated with RNase inhibitors, nucleic acid stabilizers (e.g., guanidine isothiocyanate), and buffering components, designed to rapidly inactivate endogenous and exogenous RNases, prevent RNA degradation, and maintain the structural and molecular integrity of RNA in various biological samples (including cells, tissues, blood, saliva, and cultured microorganisms) during collection, transport, and storage. It eliminates the need for immediate sample freezing or RNA extraction, adapts to diverse temperature conditions (ambient, low-temperature, or ultra-low-temperature) for short-to-long-term preservation, and ensures the extracted RNA meets the quality requirements of downstream applications such as reverse transcription-polymerase chain reaction (RT-PCR), RNA sequencing, and gene expression analysis.
In 2025, global RNA Sample Preservation Solution production reached approximately 52,800 K units, with an average global market price of around US$ 5 per unit.
The RNA Sample Preservation Solution market is surging on the crest of a biotechnological wave, fueled by: Growing adoption of RNA-based research: RNA's role in understanding gene expression and disease mechanisms drives demand for reliable preservation solutions. Advancements in RNA sequencing and analysis: Increased sensitivity and affordability of RNA sequencing techniques unlock new avenues for research and diagnostics. Expansion of personalized medicine: Personalized medicine relies heavily on RNA analysis, further bolstering market demand. Rise of liquid biopsies: Minimally invasive liquid biopsies using circulating RNA are gaining traction, necessitating stable sample preservation. Challenges and Opportunities: Competition and price pressure: Intense competition, particularly from low-cost manufacturers, can impact profit margins. Stringent regulations and certifications: Complying with quality and safety standards can be complex and costly. Evolving research needs: Keeping pace with advancements in RNA-based technologies requires continuous innovation. Sustainability concerns: Developing eco-friendly formulations and reducing plastic waste are growing priorities.
LP Information, Inc. (LPI) ' newest research report, the “RNA Sample Preservation Solution Industry Forecast” looks at past sales and reviews total world RNA Sample Preservation Solution sales in 2025, providing a comprehensive analysis by region and market sector of projected RNA Sample Preservation Solution sales for 2026 through 2032. With RNA Sample Preservation Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Sample Preservation Solution industry.
This Insight Report provides a comprehensive analysis of the global RNA Sample Preservation Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNA Sample Preservation Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNA Sample Preservation Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Sample Preservation Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Sample Preservation Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of RNA Sample Preservation Solution market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Inactivated
Non-inactivated
Segmentation by Preservation Temperature Requirement:
Ambient Temperature Preservation Solution
Low-Temperature Preservation Solution
Ultra-Low Temperature Preservation Solution
Segmentation by Target Sample Type:
Swab Sample Preservation Solution
Tissue Sample Preservation Solution
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Longhorn Vaccines and Diagnostics
EKF Diagnostics Holdings
Biosigma
BIOBASE
BD
Aptaca
Orient Gene
Mole Bioscience
Biocomma
Beijing Hanbaihan Medical
Darui Biotech
Hangzhou LifeReal Biotechnology
Copan Diagnostics
BioServUK
Guangdong Hybribio Biotech
Haimen Shengbang Laboratory Equipment
Longsee Biomedical
Hangzhou Jiuyang Biotechnology
Jifan Biotechnology (Beijing)
Puritan Medical Products
Cardinal Health
Medline Industries
Shandong Chengwu Medical Products Factory
Key Questions Addressed in this Report
What is the 10-year outlook for the global RNA Sample Preservation Solution market?
What factors are driving RNA Sample Preservation Solution market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do RNA Sample Preservation Solution market opportunities vary by end market size?
How does RNA Sample Preservation Solution break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
RNA Sample Preservation Solution is a specialized biological reagent formulated with RNase inhibitors, nucleic acid stabilizers (e.g., guanidine isothiocyanate), and buffering components, designed to rapidly inactivate endogenous and exogenous RNases, prevent RNA degradation, and maintain the structural and molecular integrity of RNA in various biological samples (including cells, tissues, blood, saliva, and cultured microorganisms) during collection, transport, and storage. It eliminates the need for immediate sample freezing or RNA extraction, adapts to diverse temperature conditions (ambient, low-temperature, or ultra-low-temperature) for short-to-long-term preservation, and ensures the extracted RNA meets the quality requirements of downstream applications such as reverse transcription-polymerase chain reaction (RT-PCR), RNA sequencing, and gene expression analysis.
In 2025, global RNA Sample Preservation Solution production reached approximately 52,800 K units, with an average global market price of around US$ 5 per unit.
The RNA Sample Preservation Solution market is surging on the crest of a biotechnological wave, fueled by: Growing adoption of RNA-based research: RNA's role in understanding gene expression and disease mechanisms drives demand for reliable preservation solutions. Advancements in RNA sequencing and analysis: Increased sensitivity and affordability of RNA sequencing techniques unlock new avenues for research and diagnostics. Expansion of personalized medicine: Personalized medicine relies heavily on RNA analysis, further bolstering market demand. Rise of liquid biopsies: Minimally invasive liquid biopsies using circulating RNA are gaining traction, necessitating stable sample preservation. Challenges and Opportunities: Competition and price pressure: Intense competition, particularly from low-cost manufacturers, can impact profit margins. Stringent regulations and certifications: Complying with quality and safety standards can be complex and costly. Evolving research needs: Keeping pace with advancements in RNA-based technologies requires continuous innovation. Sustainability concerns: Developing eco-friendly formulations and reducing plastic waste are growing priorities.
LP Information, Inc. (LPI) ' newest research report, the “RNA Sample Preservation Solution Industry Forecast” looks at past sales and reviews total world RNA Sample Preservation Solution sales in 2025, providing a comprehensive analysis by region and market sector of projected RNA Sample Preservation Solution sales for 2026 through 2032. With RNA Sample Preservation Solution sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNA Sample Preservation Solution industry.
This Insight Report provides a comprehensive analysis of the global RNA Sample Preservation Solution landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNA Sample Preservation Solution portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNA Sample Preservation Solution market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNA Sample Preservation Solution and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNA Sample Preservation Solution.
This report presents a comprehensive overview, market shares, and growth opportunities of RNA Sample Preservation Solution market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Inactivated
Non-inactivated
Segmentation by Preservation Temperature Requirement:
Ambient Temperature Preservation Solution
Low-Temperature Preservation Solution
Ultra-Low Temperature Preservation Solution
Segmentation by Target Sample Type:
Swab Sample Preservation Solution
Tissue Sample Preservation Solution
Others
Segmentation by Application:
Hospital
Clinic
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific
Longhorn Vaccines and Diagnostics
EKF Diagnostics Holdings
Biosigma
BIOBASE
BD
Aptaca
Orient Gene
Mole Bioscience
Biocomma
Beijing Hanbaihan Medical
Darui Biotech
Hangzhou LifeReal Biotechnology
Copan Diagnostics
BioServUK
Guangdong Hybribio Biotech
Haimen Shengbang Laboratory Equipment
Longsee Biomedical
Hangzhou Jiuyang Biotechnology
Jifan Biotechnology (Beijing)
Puritan Medical Products
Cardinal Health
Medline Industries
Shandong Chengwu Medical Products Factory
Key Questions Addressed in this Report
What is the 10-year outlook for the global RNA Sample Preservation Solution market?
What factors are driving RNA Sample Preservation Solution market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do RNA Sample Preservation Solution market opportunities vary by end market size?
How does RNA Sample Preservation Solution break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
154 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for RNA Sample Preservation Solution by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for RNA Sample Preservation Solution by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
